跳至主要内容
临床试验/IRCT201010033461N3
IRCT201010033461N3已完成未知

The comparative study of the effects of methotrexate and combination of methotrexate-mifepristone in treatment of ectopic pregnancy

Kermanshah University of Medical Sciences0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 45 years(—)
性别
Female

入选标准

  • stable Hemodynamic state, Without Bleeding or hemo-peritoneum, un ruptured ectopic pregnancy, ectopic pregnancy mass without FHR, ectopic pregnancy mass smaller than 4cm, BHCG less than 1500 mlu/ml, no contradiction of use of methotrexate or mifepristone
  • Exclusion criteria: decrease in serum BHCG, BHCG less than1500 mlu/ml and depletion after 48 h, history of liver and renal diseases, hematologic or others disorders such as: glaucoma, porphyria, thalassemia, ulcerative colitis, heart diseases, psychological diseases, corticosteroid use more than 6 months, prior sensitivity to methotrexate or mifepristone

排除标准

  • 未提供

研究者

相似试验